The Venture Codex

Participated · Series A · Jul 2021

Truveta aggregates de-identified EHR data from a coalition of health systems into Truveta Data, a daily-updated, regulatory-grade dataset representing over 120 million patients. Launched in 2020, the company is a collaboration of some 30 health systems aligned on a mission to save lives with data. Its platform includes the Truveta Language Model, a large-language, multimodal AI model run on Microsoft Azure to normalize and transform billions of data points. Truveta is expanding into genotypic data through the Truveta Genome Project to link exomes and future multi-omics sequencing to clinical records. The combined genotypic and phenotypic database is intended for biopharma and academic research to accelerate drug discovery, optimize clinical trials, and train AI models. Data privacy and de-identification, along with Azure as the exclusive cloud provider for the genome project, are core operational elements described in the articles. Truveta collects privacy-safe, de-identified medical data from partner health systems and aggregates it for researchers. It partners with around 20 medical providers and ingests regular data from 42 states, aiming to build a living medical portrait of America. The company provides a software service that lets public-health researchers filter populations and drop into a Jupyter Notebook to build dashboards with data that updates daily. CEO Terry Myerson, formerly of Microsoft, says Truveta has its sights on 16% of all clinical care in the United States. Truveta has shared COVID-19 analyses from its platform, including findings that adverse events occur in fewer than 1% of fully vaccinated people and that Moderna patients showed 40% more events than Pfizer in their dataset. The company is not a nonprofit (it pays taxes), maintains an anti-advertising stance licensed for ethical medical research, and recently raised $100 million, bringing its capital base to around $200 million. Truveta operates a provider-led platform that brings together daily de-identified clinical data from its member health systems to deliver insights to clinicians and researchers. The platform aggregates tens of millions of patients and thousands of care facilities across 40 states and represents more than 15% of U.S. patient care. Truveta aims to help researchers find cures faster, empower clinicians with better data, and improve treatment and outcomes for diverse populations. The company emphasizes statistical representation across geography, race, ethnicity and other socioeconomic dimensions to address health disparities. Governance and investment come from its health system members, and earnings health providers receive from Truveta are intended to be reinvested into their communities. Truveta plans to hire technologists and health-data experts and invest in infrastructure and cloud-computing resources to build and scale the platform.